Catib, Cassandra .
HRN: 26-18-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/06/2024
11/13/2024
IV
350
Q8h
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes